04:03 AM EDT, 09/26/2024 (MT Newswires) -- BioAge Labs (BIOA) said late Wednesday it has priced an upsized initial public offering of 11 million shares at $18 per share for expected gross proceeds of $198 million.

The company said its shares will begin trading on the Nasdaq Global Select Market on Thursday under the ticker 'BIOA.'

The clinical-stage biopharmaceutical company granted underwriters a 30-day option to purchase up to an additional 1.7 million shares.

The offering is expected to close on Friday.